Method of correcting HERG channel dysfunction

Abstract

A method of shortening prolonged QT intervals in a patient with a trafficking defective HERG mutation is disclosed. In one embodiment, this method comprises the step of treating the patient with an effective amount of fexofenadine whereby the patient's prolonged QT interval is shortened.

1 . A method of shortening prolonged QT intervals in a patient with a trafficking defective HERG mutation, wherein the mutation is treating the patient with an effective amount of fexofenadine, whereby the patient's prolonged QT interval is shortened.  
     
     
         2 . The method of  claim 1  wherein the patient has a N47OD or G601S mutation.  
     
     
         3 . The method of  claim 1  wherein the fexofenadine is taken orally.  
     
     
         4 . The method of  claim 1  wherein the amount of fexofenadine is between 40-80 mg every 12 hours.  
     
     
         5 . The method of  claim 1  wherein the amount of fexofenadine is between 100-250 mg daily.  
     
     
         6 . The method of  claim 1  wherein the patient is monitored via an ECG.  
     
     
         7 . The method of  claim 1  additionally comprising the step of evaluating the patient's fexofenadine plasma levels after fexofenadine has been administered to the patient.